CORONAVIRUS DISEASE COVID 19 NEWS AND RESEARCH
Latest Coronavirus Disease COVID 19 News and Research
Health officials worry nation is not ready for COVID-19 vaccine
Millions of Americans are counting on a COVID-19 vaccine to curb the global pandemic and return life to normal.
When the pandemic closes your gym, ‘come for the party, stay for the workout’
Evaristo "Risto" Grant counted down from 10 as his clients held their plank positions and shook with the effort. Michael Jackson's "Wanna Be Startin' Somethin'" blared in the background. Grant paced around his clients on their yoga mats, shouting words of encouragement.
_56406cb33bb64e5d928759d4eef45c31-150x125.jpg "Durable IgG antibodies to SARS-CoV-2 from the Iceland experience")
Durable IgG antibodies to SARS-CoV-2 from the Iceland experience
Now, a team of scientists at the Reykjavik-based deCODe Genetics, a subsidiary of the U.S. biotech company Amgen, and several universities and hospitals in Iceland, says that the antibodies developed to fight SARS-CoV-2 last for at least four months and do not fade quickly as previously thought.
Exponential rise in COVID-19 hospitalization risk with age due to waning T cell immunity
The age-related increase in the risk of severe disease and death from COVID-19 mirrors earlier patterns seen with infections. Such trends may help understand the mechanisms underlying the clinical feature. A recent study published in the preprint server medRxiv* in August 2020 shows the effect of age and sex on COVID-19 hospitalization rates in the USA and helps understand how immune function is involved in this pandemic.
A global vaccine is sufficient to combat COVID-19 infection, indicates study
Genetic analysis of sequences from more than 27,000 individuals infected with the coronavirus that causes COVID-19 reveals that the virus has mutated minimally since December 2019, suggesting one vaccine would be sufficient to combat global infections.
_f867a24761694ba28984cfae03a06286-150x125.jpg "ACE2/TMPRSS2 not expressed in pancreatic islet endocrine cells")
ACE2/TMPRSS2 not expressed in pancreatic islet endocrine cells
A new study by researchers at the Vanderbilt University Medical Center and the University of Pennsylvania Perelman School of Medicine and published on the preprint server bioRxiv* in August 2020 reports that both key enzymes that are required for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) entry into the human host cell are lacking in the beta cells of the pancreatic islet. This rules out the direct injury hypothesis for impaired glucose control in patients with COVID-19 disease.
High-pressure preconcentration devices for detecting small amounts of virus in early infections
Diagnostic devices that are used at home or in doctors' offices are often not sensitive enough to detect small amounts of a virus that might be present in samples from asymptomatic patients, which can occur in early stage COVID-19.
Study shows unprecedented impact of COVID-19 on surgical care in Ontario
The estimated time to clear surgeries postponed in Ontario because of the coronavirus disease 2019 (COVID-19) pandemic is 84 weeks, with a target of 717 surgeries per week, according to a new modelling study in CMAJ.
_326bbcadf7a64b5cbe62d8eba4e09d92-150x125.jpg "SARS-CoV-2-RNA viremia is a robust marker of critical illness in COVID-19")
SARS-CoV-2-RNA viremia is a robust marker of critical illness in COVID-19
A new study by a large team of Spanish researchers and published on the preprint server medRxiv* in August 2020 reports that the presence of viral RNA in the blood is a useful marker of impending acute disease and can help triage COVID-19 disease patients who will require hospital care.
Addressing food insecurity in school children during COVID-19 pandemic
The coronavirus pandemic has brought a number of challenges to schools, which were forced to close in the spring to help slow the spread of infection.
Negligible ACE2 expression in human beta-cells
Now, a new study published on the preprint server bioRxiv reports that even though the fatality rate is significantly higher in diabetics, there is no evidence that this is due to direct viral infection of pancreatic beta cells, which produce the key hormone in glucose homeostasis, namely insulin.
HSS physicians offer practical advice for educators and surgical trainees on reaching peak performance
Studies show that athletes and musicians achieve peak performance not only by constant practice but also by setting specific goals, engaging with strong mentors and cultivating the attributes of perseverance, stoicism and grit.
Health expert warns of the increasing threat of animal-to-human coronaviruses
The coronavirus outbreaks, including the severe acute respiratory syndrome (SARS), the Middle East respiratory syndrome (MERS), and the currently spreading coronavirus disease (COVID-19), all came via animal-to-human transmission or zoonosis.
SARS-CoV-2 is more resistant on surfaces in spring and autumn than in summer
In a recent bioRxiv* preprint paper, researchers from Kansas State University demonstrate astonishing persistence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on various types of surfaces – especially under spring/fall climate conditions.
COVID-19 testing and reporting needs improving in United States prisons
Researchers at the University of North Carolina at Chapel Hill and Cornell University have conducted a study showing that many states across the US are not reporting fully on the number of people being tested for coronavirus disease 2019 (COVID-19) in prisons, with some also not reporting on cases of fatalities.
Dr. Fauci says COVID vaccine trials could end early if results are overwhelming
A COVID-19 vaccine could be available earlier than expected if ongoing clinical trials produce overwhelmingly positive results, said Dr. Anthony Fauci, the nation's top infectious disease official, in an interview Tuesday with KHN.
_c51f043005954177ace66c3bf11d9eae-150x125.jpg "Promising new candidate 'virus-like particle' vaccine for COVID-19")
Promising new candidate 'virus-like particle' vaccine for COVID-19
Researchers in the UK and Taiwan have demonstrated the potential of a new candidate vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the virus responsible for the current coronavirus disease 2019 (COVID-19) pandemic.
BCG vaccine offers protection for elderly people against respiratory infections
The BCG vaccine has a broad, stimulating effect on the immune system. This gives it an effective preventive action against various infections - possibly also against COVID-19. New studies are investigating that.
Common heart drugs are safe for patients hospitalized with COVID-19
Heart patients hospitalized with COVID-19 can safely continue taking angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), according to the BRACE CORONA trial presented in a Hot Line session today at ESC Congress 2020.
Public health officials are our COVID commanders. Treat them with respect.
As a veteran who served back-to-back tours in Iraq, I initially cringed when commentators compared the COVID-19 crisis to wartime — no bullets, no blood and no one volunteered for this.
.png)
No hay comentarios:
Publicar un comentario